Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028189
Filing Date
2024-12-03
Accepted
2024-12-03 18:11:01
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 form4-12032024_111255.html 4  
1 form4-12032024_111255.xml 4 5330
  Complete submission text file 0001415889-24-028189.txt   6886
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Issuer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O CELCUITY, 16305 36TH AVENUE N. #100 MINNEAPOLIS MN 55445
Business Address
Furcht Leo (Reporting) CIK: 0001775749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38207 | Film No.: 241524071